Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-07-29
1995-05-23
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 77, 544125, 544361, A61K 3158
Patent
active
054182387
ABSTRACT:
A compound of formula (I): ##STR1## wherein R is a hydrogen atom or a C.sub.1 -C.sub.4 alkyl group;
REFERENCES:
patent: 5155107 (1992-10-01), Panzeri et al.
patent: 5302621 (1994-04-01), Kojima et al.
Liang et al. J. Steroid Biochem. vol. 19 No. 1 pp. 385-390 (1983).
Lamb et al. The Prostate vol. 21 pp. 15-34 (1992).
Stinson, Chem. and Eng. News, Jun. 29, 1992 pp. 7 and 8.
Journal of Medicinal Chemistry, vol. 29, No. 11, Nov. 1, 1986, Gary H. Rasmusson, et al., "Azasteroids: Structure-Activity Relationships for Inhibition of 5-.alpha.-Reductase and of Androgen Receptor Binding", pp. 2298-2315.
Journal of Medicinal Chemistry, vol. 27, No. 12, Dec. 1984, Gary H. Rasmusson, et al., "Azasteroids as Inhibitors of Rat Prostatic 5-.alpha.-Reductase", pp. 1690-1701.
Di Salle Enrico
Nesi Marcella
Panzeri Achille
Daus Donald G.
Farmitalia Carlo Erba S.r.l.
LandOfFree
17.beta.-substituted 4-aza-5.alpha.-androstan-3-one derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 17.beta.-substituted 4-aza-5.alpha.-androstan-3-one derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 17.beta.-substituted 4-aza-5.alpha.-androstan-3-one derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2140643